Clinical Trial Update: A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC [Phase 2]

View source ↗

Summary

A single-arm, prospective Phase II trial assessing Utidelone plus capecitabine for active brain metastases in triple-negative metastatic breast cancer is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Utidelone (utidelone)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING